Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Brian Butler

Showing results (151-160 of 164) with videos related to

Pageof 17
Sort By:
Urologic Oncology|February 26, 2013
Combined therapeutic effects of adenoviral vector-mediated GLIPR1 gene therapy and radiotherapy in prostate and bladder cancer modelsTetsuo Fujita, Takefumi Satoh, Terry L Timme, et al.
International Journal of Radiation Oncology, Biology, Physics|April 16, 2003
Dosimetric predictors of xerostomia for head-and-neck cancer patients treated with the smart (simultaneous modulated accelerated radiation therapy) boost techniqueChad M Amosson, Bin S Teh, T John Van, et al.
Journal of Contemporary Brachytherapy|December 9, 2020
Eye plaque brachytherapy versus enucleation for ocular melanoma: an analysis from the National Cancer DatabaseJay A Messer, Raed J Zuhour, Waqar Haque, et al.
International Journal of Radiation Oncology, Biology, Physics|April 16, 2003
IMRT for prostate cancer: defining target volume based on correlated pathologic volume of diseaseBin S Teh, Michael D Bastasch, Thomas M Wheeler, et al.
International Journal of Radiation Oncology, Biology, Physics|February 19, 2002
Intensity-modulated radiation therapy for pediatric medulloblastoma: early report on the reduction of ototoxicityEugene Huang, Bin S Teh, Douglas R Strother, et al.
Stem Cell Reports|November 7, 2017
Differentiation of Human Induced Pluripotent or Embryonic Stem Cells Decreases the DNA Damage Repair by Homologous RecombinationKalpana Mujoo, Raj K Pandita, Anjana Tiwari, et al.
International Journal of Radiation Oncology, Biology, Physics|February 18, 2004
Hypofractionated intensity-modulated radiotherapy for primary glioblastoma multiformeNathan S Floyd, Shiao Y Woo, Bin S Teh, et al.
International Journal of Radiation Oncology, Biology, Physics|May 18, 2004
Enhanced systemic T-cell activation after in situ gene therapy with radiotherapy in prostate cancer patientsTakefumi Satoh, Bin S Teh, Terry L Timme, et al.
Technology in Cancer Research & Treatment|January 19, 2006
Expanding the therapeutic index of radiation therapy by combining in situ gene therapy in the treatment of prostate cancerMichael T Tetzlaff, Bin S Teh, Terry L Timme, et al.
International Journal of Radiation Oncology, Biology, Physics|March 31, 2004
Phase I-II trial evaluating combined intensity-modulated radiotherapy and in situ gene therapy with or without hormonal therapy in treatment of prostate cancer-interim report on PSA response and biopsy dataBin S Teh, Gustavo Ayala, Laura Aguilar, et al.
Pageof 17

Showing results (151-160 of 164) with videos related to

Sort By:
Pageof 17
Urologic Oncology|February 26, 2013
Combined therapeutic effects of adenoviral vector-mediated GLIPR1 gene therapy and radiotherapy in prostate and bladder cancer modelsTetsuo Fujita, Takefumi Satoh, Terry L Timme, et al.
International Journal of Radiation Oncology, Biology, Physics|April 16, 2003
Dosimetric predictors of xerostomia for head-and-neck cancer patients treated with the smart (simultaneous modulated accelerated radiation therapy) boost techniqueChad M Amosson, Bin S Teh, T John Van, et al.
Journal of Contemporary Brachytherapy|December 9, 2020
Eye plaque brachytherapy versus enucleation for ocular melanoma: an analysis from the National Cancer DatabaseJay A Messer, Raed J Zuhour, Waqar Haque, et al.
International Journal of Radiation Oncology, Biology, Physics|April 16, 2003
IMRT for prostate cancer: defining target volume based on correlated pathologic volume of diseaseBin S Teh, Michael D Bastasch, Thomas M Wheeler, et al.
International Journal of Radiation Oncology, Biology, Physics|February 19, 2002
Intensity-modulated radiation therapy for pediatric medulloblastoma: early report on the reduction of ototoxicityEugene Huang, Bin S Teh, Douglas R Strother, et al.
Stem Cell Reports|November 7, 2017
Differentiation of Human Induced Pluripotent or Embryonic Stem Cells Decreases the DNA Damage Repair by Homologous RecombinationKalpana Mujoo, Raj K Pandita, Anjana Tiwari, et al.
International Journal of Radiation Oncology, Biology, Physics|February 18, 2004
Hypofractionated intensity-modulated radiotherapy for primary glioblastoma multiformeNathan S Floyd, Shiao Y Woo, Bin S Teh, et al.
International Journal of Radiation Oncology, Biology, Physics|May 18, 2004
Enhanced systemic T-cell activation after in situ gene therapy with radiotherapy in prostate cancer patientsTakefumi Satoh, Bin S Teh, Terry L Timme, et al.
Technology in Cancer Research & Treatment|January 19, 2006
Expanding the therapeutic index of radiation therapy by combining in situ gene therapy in the treatment of prostate cancerMichael T Tetzlaff, Bin S Teh, Terry L Timme, et al.
International Journal of Radiation Oncology, Biology, Physics|March 31, 2004
Phase I-II trial evaluating combined intensity-modulated radiotherapy and in situ gene therapy with or without hormonal therapy in treatment of prostate cancer-interim report on PSA response and biopsy dataBin S Teh, Gustavo Ayala, Laura Aguilar, et al.
Pageof 17